Save Sight Institute

Sydney, New South Wales 2000

1 studies enrolling now · 8 studies all time

What they study most

Anterior Ischemic Optic Neuropathy, Branch Retinal Vein Occlusion, Central Retinal Vein Occlusion, Geographic Atrophy, Hemiretinal Vein Occlusion, Macular Edema, Macular Telangiectasia Type 2, Macular Telangiectasia Type 2 (MacTel)

Studies at this site

• Study of Serine Supplementation to Protect Vision in MacTel — Starting soon
• Safety Study to Evaluate Bilateral CNTF Implants in Subjects With MacTel Type 2 — Completed
• A Study to Evaluate the Efficacy and Safety of Faricimab in Participants With Macular Edema Secondary to Branch Retinal Vein Occlusion — Completed
• A Study to Evaluate the Efficacy and Safety of Faricimab in Participants With Macular Edema Secondary to Central Retinal or Hemiretinal Vein Occlusion — Completed
• A Study Investigating the Efficacy and Safety of Lampalizumab Intravitreal Injections in Participants With Geographic Atrophy Secondary to Age-Related Macular Degeneration — Stopped early
• Long-Term Safety of Lampalizumab Intravitreal (ITV) Injections in Participants With Geographic Atrophy (GA) Secondary to Age-Related Macular Degeneration (OMASPECT) — Stopped early
• PDE5 Inhibitor Use and Non-arteritic Anterior Ischemic Optic Neuropathy (NAION) — Stopped early
• A Phase 2 Multicenter Randomized Clinical Trial of CNTF for MacTel — Completed